Swissmedic Expands Use of Breyanzi®: Updated Authorization Details
On November 22, 2025, Swissmedic announced the extension of the therapeutic indication for Breyanzi® (lisocabtagene maraleucel). This change has important
On November 22, 2025, Swissmedic announced the extension of the therapeutic indication for Breyanzi® (lisocabtagene maraleucel). This change has important
Health Canada has published updated guidelines for managing medical device license applications. These regulations aim to enhance clarity for manufacturers,
NOxBOX Ltd., a subsidiary of Linde Gas & Equipment Inc., has announced a critical correction for its NOxBOXi Nitric Oxide
A new clinical trial is set to evaluate the performance and safety of a polymer artificial heart valve specifically designed
A new post-market observational clinical study focused on the medical device SPHEREPLAST has been announced by MT Ortho s.r.l., targeting
On November 22, 2025, the National Institute of Geriatrics, Rheumatology, and Rehabilitation in Poland announced new advancements in the management
On November 22, 2025, a pivotal clinical trial examining the link between muscle oxygenation and upper limb exercise capacity in
Neudive Inc. has announced a new clinical trial to evaluate its digital therapeutic device, NDTx-02, for improving executive function in
Kanuni Sultan Suleyman Training and Research Hospital has announced an important clinical trial comparing the effectiveness of two pain management
Siemens Healthineers has announced corrective actions for its 3 Tesla MRI systems, addressing a potentially severe safety risk that may